Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-031576

Interim CEO & General Counsel gave up 11,449 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 41,662 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-04 Exercise or conversion : show line 1 in the form +41,662 140,800 D
2024-03-04 Shares withheld for taxes : show line 2 in the form −11,449 $16.96 $194,175 129,351 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-04 Exercise or conversion : show line 3 in the form Restricted Stock Units −41,662 83,338 D
Loading xslF345X05/tm248073-2_4seq1.xml…